Medication Scheme Implementation Guide
1.0.0 - draft Estonia flag

Medication Scheme Implementation Guide, published by TEHIK. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/TEHIK-EE/ig-ee-medication-scheme/ and changes regularly. See the Directory of published versions

: renal-function-failure - XML Representation

Raw xml | Download


<ClinicalUseDefinition xmlns="http://hl7.org/fhir">
  <id value="renal-function-failure"/>
  <meta>
    <profile
             value="https://fhir.ee/StructureDefinition/ee-tis-renal-failure-ds"/>
  </meta>
  <language value="et"/>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml" xml:lang="et" lang="et"><p class="res-header-id"><b>Generated Narrative: ClinicalUseDefinition renal-function-failure</b></p><a name="renal-function-failure"> </a><a name="hcrenal-function-failure"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Language: et</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ee-tis-renal-failure-ds.html">EETISRenalFailureDS</a></p></div><p><b>ExtensionEETISAffectedMedicationStatements</b>: <a href="MedicationStatement-MedicationStatement-metformin.html">MedicationStatement: extension = ,100,2023-11-07,,,Avalik,order,; status = recorded; category = Pidev,Tavaretsept,3-kordne; effective[x] = 2015-02-07 13:28:17-0500 --&gt; (ongoing); note = patsient peaks iga päev veresuhkrut mõõtma</a></p><p><b>ExtensionEETISAdditionalInformationLink</b>: www.synbase.ee/metformin-neerufunktsioon</p><p><b>ExtensionEETISNephrotoxic</b>: false</p><blockquote><p><b>ExtensionEETISDosageModification</b></p><ul><li>dosageIntervalMin: 6</li><li>dosageIntervalMax: 12</li><li>recommendation: Siin on soovitused</li></ul></blockquote><p><b>ExtensionEETISRelatedObservationOrCondition</b>: <a href="Observation-observation-egfr1.html">Observation 62238-1</a></p><p><b>type</b>: Undesirable Effect</p><p><b>category</b>: <span title="Codes:{https://fhir.ee/drug-form-group 2}">Kirjeldus siia text alla, kui on veel vaja midagi lisada</span>, <span title="Codes:{https://fhir.ee/failure-degree 1}">Kirjeldus siia text alla, kui on veel vaja midagi lisada</span>, <span title="Codes:">Kuna vosoritiidi ohutust ja efektiivsust neerukahjustuse korral ei ole hinnatud [(1)],[(2)], ei saa tõenduspõhiseid soovitusi anda. Siiski, tuginedes eliminatsioonimehhanismile, ei mõjuta neerupuudulikkus ilmselt vosoritiidi farmakokineetikat. Vosoritiid on modifitseeritud C-tüüpi natriureetiline peptiid. Vosoritiidi metabolism toimub eeldatavasti kataboolsete radade kaudu ja laguneb väikesteks peptiidideks ja aminohapeteks [(1)], [(2)].</span></p><p><b>subject</b>: <a href="#hcrenal-function-failure/metformin">Medication: extension = metformiin; identifier = https://fhir.ee/CodeSystem/tis-fhir-identifikaatorid#ravimiregister-pakend#123456; doseForm = tablett+õhukese polümeerikattega tablett; totalVolume = 120</a></p><p><b>status</b>: <span title="Codes:">active</span></p><h3>UndesirableEffects</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Classification</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://fhir.ee/synbase-warning-classification C}">Kui on veel vaja midagi lisada</span></td></tr></table><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Medication #metformin</b></p><a name="renal-function-failure/metformin"> </a><a name="hcrenal-function-failure/metformin"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Language: et</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ee-tis-medication-epc.html">EETISMedicationEPC</a></p></div><p><b>ExtensionEETISMedicinalProductClassification</b>: <span title="Codes:{https://fhir.ee/CodeSystem/atc-ee A10BA02}">metformiin</span></p><p><b>identifier</b>: <code>https://fhir.ee/CodeSystem/tis-fhir-identifikaatorid#ravimiregister-pakend</code>/123456</p><p><b>doseForm</b>: <span title="Codes:{https://fhir.ee/CodeSystem/ravimvormid 1518}">tablett+õhukese polümeerikattega tablett</span></p><p><b>totalVolume</b>: 120</p><blockquote><p><b>ingredient</b></p><h3>Items</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://fhir.ee/CodeSystem/toimeained 11354}">metformiin</span></td></tr></table><p><b>isActive</b>: true</p><p><b>strength</b>: 500(unit MG from https://fhir.ee/CodeSystem/retsept-mahu-ja-massiyhik)<span style="background: LightGoldenRodYellow"> (Details: retsept-mahu-ja-massiyhik  codeMG = 'MG')</span>/1(unit TABL from https://fhir.ee/CodeSystem/retsept-mahu-ja-massiyhik)<span style="background: LightGoldenRodYellow"> (Details: retsept-mahu-ja-massiyhik  codeTABL = 'TABLETTI')</span></p></blockquote></blockquote></div>
  </text>
  <contained>
    <Medication>
      <id value="metformin"/>
      <meta>
        <profile
                 value="https://fhir.ee/StructureDefinition/ee-tis-medication-epc"/>
      </meta>
      <language value="et"/>
      <extension
                 url="https://fhir.ee/StructureDefinition/ee-tis-medicinal-product-classification">
        <valueCodeableConcept>
          <coding>
            <system value="https://fhir.ee/CodeSystem/atc-ee"/>
            <code value="A10BA02"/>
            <display value="metformiin"/>
          </coding>
        </valueCodeableConcept>
      </extension>
      <identifier>
        <system
                value="https://fhir.ee/CodeSystem/tis-fhir-identifikaatorid#ravimiregister-pakend"/>
        <value value="123456"/>
      </identifier>
      <doseForm>
        <coding>
          <system value="https://fhir.ee/CodeSystem/ravimvormid"/>
          <code value="1518"/>
          <display value="tablett+õhukese polümeerikattega tablett"/>
        </coding>
      </doseForm>
      <totalVolume>
        <value value="120"/>
      </totalVolume>
      <ingredient>
        <item>
          <concept>
            <coding>
              <system value="https://fhir.ee/CodeSystem/toimeained"/>
              <code value="11354"/>
              <display value="metformiin"/>
            </coding>
          </concept>
        </item>
        <isActive value="true"/>
        <strengthRatio>
          <numerator>
            <value value="500"/>
            <system
                    value="https://fhir.ee/CodeSystem/retsept-mahu-ja-massiyhik"/>
            <code value="MG"/>
          </numerator>
          <denominator>
            <value value="1"/>
            <system
                    value="https://fhir.ee/CodeSystem/retsept-mahu-ja-massiyhik"/>
            <code value="TABL"/>
          </denominator>
        </strengthRatio>
      </ingredient>
    </Medication>
  </contained>
  <extension
             url="https://fhir.ee/StructureDefinition/ee-tis-affected-medication-statements">
    <valueReference>🔗 
      <reference value="MedicationStatement/MedicationStatement-metformin"/>
    </valueReference>
  </extension>
  <extension
             url="https://fhir.ee/StructureDefinition/ee-tis-additional-information-link">
    <valueString value="www.synbase.ee/metformin-neerufunktsioon"/>
  </extension>
  <extension url="https://fhir.ee/StructureDefinition/ee-tis-nephrotoxic">
    <valueBoolean value="false"/>
  </extension>
  <extension
             url="https://fhir.ee/StructureDefinition/ee-tis-dosage-modification">
    <extension url="dosageIntervalMin">
      <valueQuantity>
        <value value="6"/>
      </valueQuantity>
    </extension>
    <extension url="dosageIntervalMax">
      <valueQuantity>
        <value value="12"/>
      </valueQuantity>
    </extension>
    <extension url="recommendation">
      <valueString value="Siin on soovitused"/>
    </extension>
  </extension>
  <extension
             url="https://fhir.ee/StructureDefinition/ee-tis-related-observation-or-condition">
    <valueReference>🔗 
      <reference value="Observation/observation-egfr1"/>
    </valueReference>
  </extension>
  <type value="undesirable-effect"/>
  <category>
    <coding>
      <system value="https://fhir.ee/drug-form-group"/>
      <code value="2"/>
      <display value="süsteemne"/>
    </coding>
    <text value="Kirjeldus siia text alla, kui on veel vaja midagi lisada"/>
  </category>
  <category>
    <coding>
      <system value="https://fhir.ee/failure-degree"/>
      <code value="1"/>
      <display value="GFR 30-59 ml/min (mõõdukas neerupuudulikkus)"/>
    </coding>
    <text value="Kirjeldus siia text alla, kui on veel vaja midagi lisada"/>
  </category>
  <category>
    <text
          value="Kuna vosoritiidi ohutust ja efektiivsust neerukahjustuse korral ei ole hinnatud [(1)],[(2)], ei saa tõenduspõhiseid soovitusi anda. Siiski, tuginedes eliminatsioonimehhanismile, ei mõjuta neerupuudulikkus ilmselt vosoritiidi farmakokineetikat. Vosoritiid on modifitseeritud C-tüüpi natriureetiline peptiid. Vosoritiidi metabolism toimub eeldatavasti kataboolsete radade kaudu ja laguneb väikesteks peptiidideks ja aminohapeteks [(1)], [(2)]."/>
  </category>
  <subject>
    <reference value="#metformin"/>
  </subject>
  <status>
    <coding>
      <code value="active"/>
    </coding>
  </status>
  <undesirableEffect>
    <classification>
      <coding>
        <system value="https://fhir.ee/synbase-warning-classification"/>
        <code value="C"/>
        <display value="Annust või annustamise vahemikku tuleb kohandada"/>
      </coding>
      <text value="Kui on veel vaja midagi lisada"/>
    </classification>
  </undesirableEffect>
</ClinicalUseDefinition>